NV1020

BIOLOGICAL2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, MediGene

Conditions

Colorectal CancerLiver NeoplasmsMetastatic Cancer

Phase 1

Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver

CompletedNCT00012155

Memorial Sloan Kettering Cancer CenterColorectal Cancer, Metastatic Cancer

Start: 2000-10-31End: 2009-12-31Updated: 2013-06-26

Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

CompletedNCT00149396

MediGeneColorectal Cancer, Liver Neoplasms

Start: 2004-07-31End: 2008-12-31Updated: 2018-04-24